Vivos Therapeutics, Inc. Net Income (Loss) Attributable to Noncontrolling Interest
Vivos Therapeutics, Inc. (VVOS) reported Net Income (Loss) Attributable to Noncontrolling Interest of -$42.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-08-14
- Vivos Therapeutics, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-06-30 was -$42.00K.
- Vivos Therapeutics, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$69.00K.
- Vivos Therapeutics, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2025 was -$60.00K.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|
| 2026-06-30 | -$42.00K 10-Q · filed 2026-08-14 | -$111.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | -$69.00K 10-Q · filed 2026-05-20 | ||
| 2025-12-31 | -$60.00K 10-K · filed 2026-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |